LY3177833
≥99%
- Product Code: 101359
CAS:
1627696-51-8
| Molecular Weight: | 309.3 g./mol | Molecular Formula: | C₁₆H₁₂FN₅O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
LY3177833 is primarily investigated for its potential therapeutic applications in the field of oncology. It is being studied as an antibody-drug conjugate (ADC) designed to target specific cancer cells, delivering a cytotoxic agent directly to the tumor while minimizing damage to healthy tissues. This approach aims to improve the efficacy and reduce the side effects associated with traditional chemotherapy. Early-phase clinical trials have focused on its use in treating various solid tumors, with researchers exploring its safety, tolerability, and anti-tumor activity. The compound represents a promising avenue in targeted cancer therapy, particularly for patients with advanced or treatment-resistant cancers. Ongoing research continues to evaluate its potential in combination with other treatments to enhance overall therapeutic outcomes.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $566.85 |
+
-
|
| 0.010 | 10-20 days | $876.04 |
+
-
|
LY3177833
LY3177833 is primarily investigated for its potential therapeutic applications in the field of oncology. It is being studied as an antibody-drug conjugate (ADC) designed to target specific cancer cells, delivering a cytotoxic agent directly to the tumor while minimizing damage to healthy tissues. This approach aims to improve the efficacy and reduce the side effects associated with traditional chemotherapy. Early-phase clinical trials have focused on its use in treating various solid tumors, with researchers exploring its safety, tolerability, and anti-tumor activity. The compound represents a promising avenue in targeted cancer therapy, particularly for patients with advanced or treatment-resistant cancers. Ongoing research continues to evaluate its potential in combination with other treatments to enhance overall therapeutic outcomes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :